Florida Gastroenterological Society
Florida Gastroenterological Society

DDIs affect around 40% of HCV patients taking DAAs

Drug-drug interactions, or DDIs, affect about 40% of patients with hepatitis C virus being treated with direct-acting antivirals, or DAAs, according to a study published in Open Forum Infectious Diseases. Researchers said lower DDI potential among modern DAA regimens is counteracted by changing patient characteristics.“Despite the large improvements in the field of HCV therapy, DDIs are still relevant,” Benjamin Maasoumy, MD, clinical physician in the department of gastroenterology, hepatology and endocrinology at Hannover Medical School and the German Center for InfectionRead More

Posted in News

FGS Login Portal

Not Member yet? Register | Forgot password?